Literature DB >> 16876430

Anosmin-1 modulates the FGF-2-dependent migration of oligodendrocyte precursors in the developing optic nerve.

Ana Bribián1, María José Barallobre, Nadia Soussi-Yanicostas, Fernando de Castro.   

Abstract

Oligodendrocyte precursors (OPCs) originate at specific domains within the neural tube before migrating to colonize the entire CNS. Once in their target areas, these cells differentiate into oligodendrocytes, the myelin-forming cells in the CNS. Using the embryonic mouse optic nerve as an experimental model, we have analyzed the influence of FGF-2 on OPC development. FGF-2 exerts a dose-dependent motogenic effect on the migration of plp-dm20+ and it also acts as a chemoattractant on these cells. These effects produced by FGF-2 are principally mediated by the FGFR1 receptor, which is expressed by OPCs. Anosmin-1 is the protein that is defective in the X-linked form of human Kallmann syndrome. This protein is expressed by retinal axons and it also interacts with FGFR1, thereby impairing the migration of OPCs. Because both Anosmin-1 and FGF-2 are present in the optic nerve in vivo, we propose a model whereby the relative concentration of these two proteins modulates the migration of OPCs during development through their interaction with FGFR1. This FGF-2/FGFR1/Anosmin-1 system may be relevant in the context of demyelinating diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16876430     DOI: 10.1016/j.mcn.2006.05.009

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  24 in total

Review 1.  Glia unglued: how signals from the extracellular matrix regulate the development of myelinating glia.

Authors:  Holly Colognato; Iva D Tzvetanova
Journal:  Dev Neurobiol       Date:  2011-11       Impact factor: 3.964

Review 2.  Extracellular cues influencing oligodendrocyte differentiation and (re)myelination.

Authors:  Natalie A Wheeler; Babette Fuss
Journal:  Exp Neurol       Date:  2016-03-23       Impact factor: 5.330

Review 3.  Laminin regulates oligodendrocyte development and myelination.

Authors:  Minkyung Kang; Yao Yao
Journal:  Glia       Date:  2021-11-12       Impact factor: 7.452

Review 4.  Regulation of oligodendrocyte precursor migration during development, in adulthood and in pathology.

Authors:  Fernando de Castro; Ana Bribián; Maria Cristina Ortega
Journal:  Cell Mol Life Sci       Date:  2013-05-21       Impact factor: 9.261

Review 5.  Feedback regulation of RTK signaling in development.

Authors:  Cynthia L Neben; Megan Lo; Natalia Jura; Ophir D Klein
Journal:  Dev Biol       Date:  2017-10-26       Impact factor: 3.582

Review 6.  Genetic insights into human isolated gonadotropin deficiency.

Authors:  Ericka Barbosa Trarbach; Leticia Gontijo Silveira; Ana Claudia Latronico
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

7.  Manipulation of the recipient retinal environment by ectopic expression of neurotrophic growth factors can improve transplanted photoreceptor integration and survival.

Authors:  E L West; R A Pearson; Y Duran; A Gonzalez-Cordero; R E MacLaren; A J Smith; J C Sowden; R R Ali
Journal:  Cell Transplant       Date:  2012-02-02       Impact factor: 4.064

Review 8.  Fibroblast Growth Factor Signalling in the Diseased Nervous System.

Authors:  Lars Klimaschewski; Peter Claus
Journal:  Mol Neurobiol       Date:  2021-04-15       Impact factor: 5.590

9.  Role of the cellular prion protein in oligodendrocyte precursor cell proliferation and differentiation in the developing and adult mouse CNS.

Authors:  Ana Bribián; Xavier Fontana; Franc Llorens; Rosalina Gavín; Manuel Reina; José Manuel García-Verdugo; Juan María Torres; Fernando de Castro; José Antonio del Río
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

10.  Novel mechanisms of fibroblast growth factor receptor 1 regulation by extracellular matrix protein anosmin-1.

Authors:  Youli Hu; Scott E Guimond; Paul Travers; Steven Cadman; Erhard Hohenester; Jeremy E Turnbull; Soo-Hyun Kim; Pierre-Marc Bouloux
Journal:  J Biol Chem       Date:  2009-08-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.